HepAssis2® bioartificial liver system in treating acute‐on‐chronic liver failure patients: Findings from a phase 1 randomised, open‐label clinical trial. - Zhong, Zibiao; Liang, Wenjin; Dai, Yong'an; Xue, Chengbiao; Zhou, Dawei; Xu, Zhigao; Li, Ling; Pan, Li; He, Chongxiang; Zhou, Xin; Zhou, Wei; Zhou, Lihua; et al. (Clinical & Translational Medicine, 2026)